SubHero Banner
Text

ArmonAir® Digihaler (fluticasone propionate) – New formulation approval

February 24, 2020 - Teva announced the FDA approval of ArmonAir Digihaler (fluticasone propionate) inhalation powder, for the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older.

Download PDF